Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |